Keto for neurodegenerative conditions

Is it possible that diet and lifestyle play a role in neurodegenerative conditions such as Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis? These seemingly distinct and diverse issues have much in common at the metabolic and biochemical level. Insulin resistance is now being connected to many chronic illnesses besides the obvious ones, like type 2 diabetes and metabolic syndrome. Alzheimer’s disease is sometimes called “type 3 diabetes,” owing to alterations in the brain’s capacity to use glucose for fuel. Amy Berger will present an intriguing argument that similar metabolic problems may be occurring in other neurological and neurodegenerative conditions. She will also provide a rationale for using ketogenic diets as a nutritional intervention for these difficult-to-treat conditions.

Programme Symposium 2022 – 10:00 PM